Literature DB >> 9786500

Bradykinin B2-receptor-mediated modulation of membrane currents in guinea-pig cardiomyocytes.

N Sakamoto1, H Uemura, Y Hara, T Saito, Y Masuda, H Nakaya.   

Abstract

1. In order to define the electrophysiological mechanism(s) responsible for bradykinin (BK)-induced positive inotropic and chronotropic responses in isolated guinea-pig atria, effects of BK on the membrane currents were examined in isolated atrial cells using patch clamp techniques. 2. BK (0.1-1000 nM) increased the L-type Ca2+ current (I(Ca)), which was recorded from enzymatically-dissociated atrial myocytes by the nystatin-perforated patch method, in a concentration-dependent fashion, and the calculated EC50 value for increasing I(Ca) was 5.2 nM. In conventional ruptured patch experiments, BK inhibited the muscarinic acetylcholine receptor-operated K+ current (I(K.ACh)) that was activated by the muscarinic agonist carbachol (1 microM) with an EC50 value of 0.57 nM. Both the increase in I(Ca) and the decrease in I(K.ACh) were blocked by HOE140, a selective bradykinin B2 receptor antagonist. 3. The BK-induced inhibition of I(K.ACh) was significantly attenuated by staurosporine and calphostin C, protein kinase C inhibitors. In addition, the I(K.ACh) inhibition by BK was also attenuated by the tyrosine kinase inhibitor genistein or tyrphostin but not by daidzein, an inactive analogue of genistein. However, neither protein kinase C inhibitor nor tyrosine kinase inhibitor affected the BK-induced increase in I(Ca). 4. In the presence and absence of muscarinic stimulation, BK prolonged the action potential recorded from the atrial cells in the current clamp mode. 5. We conclude that BK increases I(Ca) and decreases I(K.ACh) in atrial cells, resulting in positive inotropic and chronotropic responses in atrial preparations. Protein kinase C activation, and possibly tyrosine kinase activation, may be involved in the B2-receptor-mediated I(K.ACh) inhibition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786500      PMCID: PMC1565618          DOI: 10.1038/sj.bjp.0702060

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.

Authors:  H Nakaya; Y Furusawa; T Ogura; M Tamagawa; H Uemura
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.

Authors:  H Fujita; T Ogura; M Tamagawa; H Uemura; T Sato; A Ishida; M Imamaki; F Kimura; M Miyazaki; H Nakaya
Journal:  Br J Pharmacol       Date:  2006-09-25       Impact factor: 8.739

3.  Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice.

Authors:  Masashi Suzuki; Norihito Sasaki; Takashi Miki; Naoya Sakamoto; Yuki Ohmoto-Sekine; Masaji Tamagawa; Susumu Seino; Eduardo Marbán; Haruaki Nakaya
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Histamine H1-receptor-mediated modulation of the delayed rectifier K+ current in guinea-pig atrial cells: opposite effects on IKs and IKr.

Authors:  Y Matsumoto; T Ogura; H Uemura; T Saito; Y Masuda; H Nakaya
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Role of sarcolemmal ATP-sensitive K+ channels in the regulation of sinoatrial node automaticity: an evaluation using Kir6.2-deficient mice.

Authors:  Koichi Fukuzaki; Toshiaki Sato; Takashi Miki; Susumu Seino; Haruaki Nakaya
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

6.  Minoxidil opens mitochondrial K(ATP) channels and confers cardioprotection.

Authors:  Toshiaki Sato; Yulong Li; Tomoaki Saito; Haruaki Nakaya
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

7.  Endostatin inhibits bradykinin-induced cardiac contraction.

Authors:  Jumpei Yasuda; Lila Takada; Yuka Kajiwara; Muneyosi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2015-06-05       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.